Diagenic, Opaldia unite for UK blood test deal
This article was originally published in Clinica
Norwegian lifesciences specialist DiaGenic has teamed up with healthcare provider Opaldia to make its gene expression tests available in the UK. The two companies will make the technology, which consists of tests for Alzheimer's disease and breast cancer, available to private patients in the UK.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.